Consort Medical

Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.

Hemel Hempstead, GB
1,973 (est)
Consort Medical is headquartered in Hemel Hempstead, GB

Consort Medical Locations

Hemel Hempstead, GB
Cambridge, GB
Northumberland, GB
North Lynn Industrial Estate, GB
Nelson, GB
Wolverton, GB
Tyne and Wear, GB
Queenborough, GB
Monheim am Rhein, DE
Zwickau, DE
Pianezza, IT

Consort Medical Metrics

Consort Medical Summary

Market capitalization

£500 M

Closing share price

Consort Medical's current market capitalization is £500 M.

Consort Medical Financials

We estimate that Consort Medical's revenue is £277 M in FY, 2016 which is 49.82% increase from the previous period.
FY, 2014FY, 2015FY, 2016


£100 M£185 M£277 M

Revenue growth, %


Cost of sales

£177 M£261 M

Gross profit

£8.16 M£16 M

Gross profit Margin, %


    Consort Medical Market Value History

    Consort Medical Online Presence

    Consort Medical News

    Consort Medical Company Life

    You may also be interested in